Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J. Jaehnig, Meenakshi Anurag, LaTerrica Williams et al.|Cell Reports Medicine|2025Cited by 3
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersLisa A. Carey, Haoquan Zhao, Chang In Moon et al.|UNC Libraries|2025Cited by 0